Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lingyang Ganmao Pian is a traditional Chinese medicine (TCM) manufactured by Liaoning Jindan Pharmaceutical. It is an approved pharmaceutical product in China, primarily indicated for the treatment of the common cold and influenza characterized by wind-heat patterns. Clinical manifestations for which it is prescribed include fever, headache, cough, dizziness, and sore throat. The formulation is a complex mixture of several traditional ingredients, most notably Cornu Saigae Tataricae (Antelope Horn), which is traditionally valued for its ability to clear heat and calm the liver. Other key components include Flos Lonicerae Japonicae (Honeysuckle) and Fructus Forsythiae Suspensae (Forsythia), both of which are widely used in TCM for their purported anti-inflammatory and detoxifying properties. As a multi-component TCM, it works through the synergistic effects of its various phytochemicals and biological constituents to restore physiological balance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lingyang ganmao pian.